NorthEast BioLab Logo | Advanced Bioanalytical Services Lab Agile Bioanalytical Services CRO
  • Expertise
    • Menu IconAll Expertise
    • Menu IconMass Spectrometry (LC-MS)
      • Menu IconMass Spectrometry Services
      • Menu IconHPLC Testing Services
    • Menu IconMeso Scale Discovery Assay
    • Menu IconELISA Assay
      • Menu IconLuminex Multiplex Assay
    • Menu IconFlow Cytometry
    • Menu IconqPCR Analysis, ddPCR Assay
    • Menu IconWestern Blot, In Cell Western
  • Services
    • Menu IconAll Services
    • Menu IconPharmacokinetics (PK) Study
      • Menu IconToxicology (Tox) Study
      • Menu IconDose Formulation Analysis
      • Menu IconPK PD Analysis
      • Menu IconDrug Metabolism and Pharmacokinetics (DMPK)
      • Menu IconADME Studies
      • Menu IconBioequivalence and Bioavailability Studies
    • Menu IconADA Assay, Neutralizing Antibody Assay
    • Menu IconMultiplex Cytokine Assay
    • Menu IconBiomarker Assay
      • Menu IconBiomarker Assay List
    • Menu IconCell-Based Assay
      • Menu IconMechanism of Action (MOA) Studies
      • Menu IconCytotoxicity Assay
      • Menu IconBiochemical Assay
    • Menu IconBioanalytical Assay Validation
  • Solutions
    • Menu IconAll Solutions
    • Menu IconClinical CRO
      • Menu IconCentral Lab Services
      • Menu IconPBMC Services
    • Menu IconGLP Laboratory
      • Menu IconBioanalysis
      • Menu IconNon-GLP Testing
    • Menu IconPreclinical CRO
    • Menu IconMethod Development, Validation, And Transfer
      • Menu IconMethod Validation
      • Menu IconMethod Development
      • Menu IconMethod Transfer
    • Menu IconAnalytical Testing
      • Menu IconDiscovery Screening Services
      • Menu IconAnalytical Quantitation
      • Menu IconCosmetic Testing
  • About Us
    • Menu IconAbout Us
    • Menu IconOverview
    • Menu IconLeadership
    • Menu IconFacility and Equipment
    • Menu IconQuality and Compliance
    • Menu IconTherapeutic Areas
    • Menu IconWhy Us?
    • Menu IconValues
    • Menu IconProcess
    • Menu IconPartners
    • Menu IconCareers
      • Business Development Associate
      • Sr. Scientist – Cell Based Assay
      • GLP Quality Assurance Manager
      • Sr. Scientist, ELISA Immunoassay Bioanalysis
      • Sr. Scientist, LC-MS/MS Bioanalysis
      • Associate Scientist, Central Laboratory Services
      • Sr. Scientist - Pharmacokinetics (PK)
      • Content Manager, Scientific and Regulatory Writing
  • Resources
    • Menu IconLearning Center
    • Menu IconBlog
    • Menu IconCase Study
    • Menu IconVideo Brochures
    • Menu IconNews and Events
    • Menu IconTestimonials
    • Menu IconContact Us
  • Request Quote
NorthEast BioLab Logo | Advanced Bioanalytical Services Lab Agile Bioanalytical Services CRO Request Quote

Expertise

  • Menu IconAll Expertise
    • Menu IconMass Spectrometry (LC-MS)
      • Menu IconMass Spectrometry Services
      • Menu IconHPLC Testing Services
    • Menu IconMeso Scale Discovery Assay
      • Menu IconELISA Assay
        • Menu IconLuminex Multiplex Assay
      • Menu IconFlow Cytometry
        • Menu IconqPCR Analysis, ddPCR Assay
          • Menu IconWestern Blot, In Cell Western

            Services

            • Menu IconAll Services
              • Menu IconPharmacokinetics (PK) Study
                • Menu IconToxicology (Tox) Study
                • Menu IconDose Formulation Analysis
                • Menu IconPK PD Analysis
                • Menu IconDrug Metabolism and Pharmacokinetics (DMPK)
                • Menu IconADME Studies
                • Menu IconBioequivalence and Bioavailability Studies
              • Menu IconADA Assay, Neutralizing Antibody Assay
                • Menu IconMultiplex Cytokine Assay
                  • Menu IconBiomarker Assay
                    • Menu IconBiomarker Assay List
                  • Menu IconCell-Based Assay
                    • Menu IconMechanism of Action (MOA) Studies
                    • Menu IconCytotoxicity Assay
                    • Menu IconBiochemical Assay
                  • Menu IconBioanalytical Assay Validation

                    Solutions

                    • Menu IconAll Solutions
                      • Menu IconClinical CRO
                        • Menu IconCentral Lab Services
                        • Menu IconPBMC Services
                      • Menu IconGLP Laboratory
                        • Menu IconBioanalysis
                        • Menu IconNon-GLP Testing
                      • Menu IconPreclinical CRO
                        • Menu IconMethod Development, Validation, And Transfer
                          • Menu IconMethod Validation
                          • Menu IconMethod Development
                          • Menu IconMethod Transfer
                        • Menu IconAnalytical Testing
                          • Menu IconDiscovery Screening Services
                          • Menu IconAnalytical Quantitation
                          • Menu IconCosmetic Testing

                        About Us

                        • Menu IconAbout Us
                          • Menu IconOverview
                            • Menu IconLeadership
                              • Menu IconFacility and Equipment
                                • Menu IconQuality and Compliance
                                  • Menu IconTherapeutic Areas
                                    • Menu IconWhy Us?
                                      • Menu IconValues
                                        • Menu IconProcess
                                          • Menu IconPartners
                                            • Menu IconCareers
                                              • Menu IconBusiness Development Associate
                                              • Menu IconSr. Scientist – Cell Based Assay
                                              • Menu IconGLP Quality Assurance Manager
                                              • Menu IconSr. Scientist, ELISA Immunoassay Bioanalysis
                                              • Menu IconSr. Scientist, LC-MS/MS Bioanalysis
                                              • Menu IconAssociate Scientist, Central Laboratory Services
                                              • Menu IconSr. Scientist - Pharmacokinetics (PK)
                                              • Menu IconContent Manager, Scientific and Regulatory Writing

                                            Resources

                                            • Menu IconLearning Center
                                              • Menu IconBlog
                                                • Menu IconCase Study
                                                  • Menu IconVideo Brochures
                                                    • Menu IconNews and Events
                                                      • Menu IconTestimonials
                                                        • Menu IconContact Us

                                                          Request Quote

                                                            Contact Us

                                                            • Home
                                                            • ELISA Assay Development & Method Development: A Step-by-Step Guide

                                                            Table of Content

                                                            • Basics of ELISA – Principles and Mechanisms
                                                            • Types of ELISAs (Direct, Indirect, Sandwich, and Competitive)
                                                            • Importance of enzyme-substrate reactions in signal detection
                                                            • How Do You Develop an ELISA Assay Step by Step?
                                                            • What Is the Best Coating Strategy for ELISA Method Development?
                                                            • How Do You Select the Right Antigen and Antibody for ELISA Assay Development?
                                                            • What Conjugate Strategy Works Best in ELISA Method Development?
                                                            • How Can You Optimize Enzymes and Chromogens in ELISA Development?
                                                            • How Do You Troubleshoot ELISA Method and Assay Development?

                                                            ELISA Assay Development & Method Development: A Step-by-Step Guide

                                                            Abhay Pandey | NorthEast BioLab
                                                            By Abhay Pandey, MBA
                                                            Share this article on:
                                                            Reading Time: 13 minutes

                                                            ELISA Assay Development & Method Development: A Step-by-Step Guide

                                                            ELISA is a powerful tool for detecting and quantifying target analytes in complex biological samples. The primary principle of ELISA assay focuses on capturing or immobilizing the target antigen on a solid surface and complexing it with an antibody linked to an enzyme. The target antigen is then detected by estimating the enzyme activity through a measurable product such as a substrate.

                                                            ELISA development includes selecting an assay format, gathering components, and developing a working protocol. Researchers consider multiple factors during ELISA development. The primary aspect of ELISA development is identifying an ideal format for the intended application. Some ELISA assay formats include direct, indirect, competitive, and sandwich ELISA assays. These assay formats have different strategies to capture and detect the target antigen. Besides, they offer distinct magnitudes of sensitivity, specificity, speed, and simplicity and require different assay components.

                                                            The current article is a comprehensive guide on ELISA development. This guide shares insights on developing an ELISA assay, identifying the best coating strategy and antigen-antibody pair, selecting the right conjugate strategy, optimizing enzymes and chromogens, and finally troubleshooting ELISA method development. So, let us dive deep into the development of the ELISA method.

                                                            Good Laboratory Practice for Nonclinical Laboratory Studies | NorthEast BioLab Food and Drug Administration (FDA | NorthEast BioLab Clinical Laboratory Improvement Amendments | NorthEast BioLab International Orgaization for Standardization |NorthEast BioLab

                                                            Basics of ELISA – Principles and Mechanisms

                                                            Binding interactions between antigen and antibody

                                                            Antigen and antibody are substantial elements that determine the specificity and sensitivity of an ELISA assay. The antigen with good stability and purity can enhance the capturing capacities of antibodies, eventually increasing assay sensitivity.

                                                            The 3D structure of an antigen binding site in the Fab section of an antibody determines the specificity and strength of an antigen-antibody interaction. The stronger the antigen-antibody interaction, the lower the antigen concentration can be detected. A critical competing element in this interaction is the cross-reactivity of an antibody to other components in the serum rather than the target antigen. Depending on whether monoclonal or polyclonal antibodies are used, polyclonal antibodies comparatively possess higher cross-reactivity than monoclonal antibodies.

                                                            In sandwich ELISA assays, researchers can use polyclonal or monoclonal antibodies as capture and detection antibodies. Monoclonal antibodies are inherently mono-specific towards a single epitope and allow detection and quantification of minute alterations in the target antigen. On the other hand, a polyclonal capture antibody can gather as much antigen as possible. Once a polyclonal capture antibody entraps a majority of antigens, a monoclonal antibody can then be used to improve assay specificity.

                                                            A crucial aspect of sandwich ELISA development is choosing a capture and detection antibody system that recognizes two distinct non-overlapping epitopes. Once an antigen attaches to the capture antibody, that detection antibody epitope should not be altered or obscured. A matched antibody pair is a set of antibodies that detect different epitopes on the same protein antigen. With matched antibody pair, capture and detection antibody systems can bind simultaneously and do not influence epitopes of each other. Besides, matched antibody pairs could be used to capture and detect a single antigen in a sandwich ELISA or related immunoassay.

                                                            Types of ELISAs (Direct, Indirect, Sandwich, and Competitive)

                                                            types of elisaSubstratePrimary
                                                            antibody
                                                            conjugate

                                                            Direct Assay

                                                            types of elisaSubstrateSecondary
                                                            antibody
                                                            conjugate
                                                            Primary
                                                            antibody

                                                            Indirect Assay

                                                            types of elisaSubstrateCapture
                                                            antibody

                                                            Capture Assay “Sandwich”

                                                            The four primary ELISA assay formats include direct, indirect, sandwich, and competitive assay. The sandwich, direct, and indirect formats differ based on the protein initially immobilized to the solid surface and the detection system. On the other hand, competitive ELISA assays are slightly different in their working principle, and they are readily adapted to all other three assay formats. However, in all formats, washing steps are critical to remove unbound protein, and blocking of wells is necessary to minimize non-specific binding. Let us understand all these ELISA assay formats in brief.

                                                            Direct ELISA assay

                                                            Direct ELISA assay was the first format developed and is one of the easiest ELISA assays. A target antigen sample is immobilized to the assay well surface where the protein binds with high affinity. An antibody conjugated to an enzyme or other detection molecule detects the target antigen.

                                                            Indirect ELISA

                                                            The primary difference between direct and indirect ELISA is the detection process, which has two steps. It involves an unlabeled primary antibody binding to a target antigen and a labeled secondary antibody against the host species of the primary antibody binding to the primary antibody for detection. This two-step process offers greater sensitivity as multiple secondary antibodies can bind to the primary antibody and produce the amplified signal for detection.

                                                            Sandwich ELISA

                                                            Sandwich ELISA has this specific name because the target antigen is sandwiched between two antibodies. A primary capture antibody immobilized on the plate surface binds to the target antigen, while a detection antibody binds to the same antigen at a different epitope. Such a unique system of matching antigen-antibody pairs makes sandwich ELISA assays much more specific than direct or indirect ELISA formats. However, without a commercial or standardized sandwich ELISA, identifying a matched antibody pair requires adequate optimization.

                                                            Competitive ELISA

                                                            Competitive ELISA is also known as inhibition ELISA since the sample competes with a reference. Each of the previous three formats can be adapted to this particular type of ELISA. There are two ways for performing competitive ELISA: one way is immobilizing reference antigen on a plate, then sample antigen competes with reference antigen for binding a labeled antibody, and the signal detected is the level of reference antigen; another way is coating the plate with primary antibody, and the sample antigen will compete with labeled antigen. In either case, more antigens in the sample will get a weaker signal because of the competitive binding.

                                                            Importance of enzyme-substrate reactions in signal detection

                                                            The enzyme-substrate reaction is crucial for signal detection in ELISA assays. The antibody-enzyme conjugate is incubated with the corresponding substrate to generate a measurable product. This product gives data on the target antigen. A robust enzyme-substrate system ensures reliable detection of target antigens in an ELISA assay.

                                                            Enzyme-labeled antibodies are critical for generating ELISA results. Conjugating enzymes with antibodies involves a stable covalent bond between an enzyme and a monoclonal or polyclonal antibody specific to the target antigen. Several reporter enzymes, such as alkaline phosphatase and horseradish peroxidase, can be used in ELISA assays. Horseradish peroxidase is a glycoprotein enzyme that can be visualized through chromogenic reactions such as chemiluminescence. On the other hand, alkaline phosphatase is a hydrolase enzyme where the signal is measured using colorimetric substrate pNPP.

                                                            The intensity of the generated signal after substrate addition is directly proportional to the total antigen concentration present in the sample. The substrate for horseradish peroxidase is hydrogen peroxide. In this substrate reaction, TMB is the most common dye used to generate the desired signal. The substrate and dye for alkaline phosphatase is pNPP. Generally, horseradish peroxidase has a faster reaction time than alkaline phosphatase and is the preferred enzyme-substrate system.

                                                            How Do You Develop an ELISA Assay Step by Step?

                                                            • Coating

                                                              1. Coating

                                                            • Analyte capture

                                                              2. Analyte capture

                                                            • Detection antibody

                                                              3. Detection antibody

                                                            • Streptavidin-enzyme conjugate

                                                              4. Streptavidin-enzyme conjugate

                                                            • Substrate addition

                                                              5. Substrate addition

                                                            • Substrate addition

                                                              6. Analysis and calculation

                                                            Although several ELISA assay variants are developed and employed in unique applications, they all have the same four primary elements. Let us explore these critical steps in ELISA assay development.

                                                            • Coating/capture: direct or indirect capture of target antigens onto the surface of microplate wells.
                                                            • Plate blocking: addition of other proteins or molecules to cover unsaturated binding sites of the assay well surface.
                                                            • Probing/detection: incubating with direct or indirect (2nd Ab) antibodies specific to the target antigen.
                                                            • Signal measurement: detecting the generated signal through direct or secondary labeled antibodies.

                                                            The fundamental step of establishing an effective ELISA assay is immobilizing the target antigen. This step is achieved indirectly through a capture antibody or directly via adsorption. The second step includes detecting the target antigen directly through labeled primary antibodies or indirectly via labeled secondary antibodies.

                                                            The sandwich ELISA assay format is one of the most widely used formats, which employs indirect immobilization and detection to identify the target antigen. This format is called sandwich assay because the target analyte is sandwiched between two antibodies, each detecting a unique epitope. The sandwich ELISA assay format is employed highly due to its specificity and sensitivity.

                                                            The following sections now dive deep into the particular nuances of different steps of ELISA assay development.

                                                            What Is the Best Coating Strategy for ELISA Method Development?

                                                            Choosing the correct coating strategy is essential for ELISA method development, ensuring optimal binding of antibodies or antigens. Although researchers use 96/ 384 well microplates made of polystyrene/polyvinyl/polypropylene, multiple solid phase materials are available during ELISA method development.

                                                            The approach used to immobilize proteins determines the core properties of an ELISA assay. In some scenarios, immobilization of proteins may lead to a complete or partial loss of their activity due to structural deformation or random orientation. Hence, to retain its entire biological activity, researchers should attach the proteins to the plate surfaces without altering their function and conformation. Generally, an ideal immobilization strategy depends on the chemical and physicochemical properties of the plate surface and the target protein. Different immobilization techniques are available. However, they primarily follow three mechanisms: covalent, physical, and bioaffinity immobilization.

                                                            How Do You Select the Right Antigen and Antibody for ELISA Assay Development?

                                                            Selecting high-affinity antigen-antibody pairs is crucial for successful ELISA assay development. Antigen and antibody pairs are critical determining factors for assay specificity and sensitivity. The stability and purity of an antigen affect the assay performance. Besides, high antigen purity enhances the capturing capacity of an antibody, eventually increasing assay sensitivity.

                                                            Researchers can use polyclonal or monoclonal antibodies to capture and detect antigens in sandwich ELISA assays. Monoclonal antibodies are inherently specific toward a single epitope and can detect and quantify minute differences in the target antigen. On the other hand, a polyclonal antibody can capture as much of the target antigen as possible. Scientists can then employ a monoclonal antibody to detect the antigen and offer enhanced specificity to the sandwich ELISA assay system.

                                                            A crucial element in sandwich ELISA assay development is that the two antibodies must identify two different non-overlapping epitopes. Most importantly, once an antigen attaches to the capture antibody, it should not alter or obscure the epitope of the detection antibody. The detection and capture antibodies that do not impact each other and can bind simultaneously to the target antigen are called matched antibody pairs. These matched antibodies are ideal for a sandwich ELISA assay.

                                                            What Conjugate Strategy Works Best in ELISA Method Development?

                                                            The ELISA signal output depends on the enzyme-labeled antibody. Conjugating an enzyme with an antibody during ELISA method development involves forming a stable covalent bond between an enzyme and a monoclonal or polyclonal antibody. However, the primary aspect of this enzyme antibody linkage is that neither the active site of an enzyme nor the antigen attachment site of an antibody is functionally altered.

                                                            Several reporter enzymes, such as alkaline phosphatase and horseradish peroxidase, can be used to generate maximum retention of both protein and enzymes. Horseradish peroxidase can be visualized through chromogenic reactions. On the other hand, alkaline phosphatase is a hydrolase enzyme, and its activity is determined often through colorimetric substrates. However, horseradish peroxidase is relatively more stable than alkaline phosphatase.

                                                            How Can You Optimize Enzymes and Chromogens in ELISA Development?

                                                            Detection is the final step in an ELISA assay system. The intensity of the generated signal post substrate addition is directly proportional to the antigen captured in the assay well and bound to the detection reagent. Hence, enzyme and chromogen selection can significantly impact the sensitivity and specificity of ELISA development.

                                                            The most common enzyme-substrate combination is horseradish peroxidase with hydrogen peroxidase and alkaline phosphatase with para nitrophenyl phosphate. Moreover, the horseradish peroxidase and hydrogen peroxide combination employs five different dyes, including OPD, DAB, TMB, 5AS, and ABTS. Besides, each of these enzyme-substrate and dye combinations has unique buffer systems and stopping solutions.

                                                            How Do You Troubleshoot ELISA Method and Assay Development?

                                                            ELISA method development includes several unique steps where potential issues may occur and influence the assay result. Hence, effective troubleshooting is essential for ELISA method development and ensuring reproducible and accurate results. The most common issues observed during ELISA assay development are related to:

                                                            • Poor standard curve
                                                            • Matrix effect
                                                            • Weak or no signal
                                                            • Poor reproducibility
                                                            • No color development or slow color development
                                                            • Low sensitivity
                                                            • Large coefficient of variation
                                                            • High background
                                                            • Positive data seen in negative controls

                                                            Let us consider some possible causes and troubleshooting tips for each of these issues observed during ELISA method development.

                                                            Poor standard curve

                                                            Possible cause: improper standard solution.
                                                            Corresponding solution: validate that dilutions are prepared correctly.

                                                            Matrix effect

                                                            Possible cause: matrix effects can be caused due to multiple components such as endogenous phospholipids, metabolites, carbohydrates, etc.
                                                            Corresponding solution: diluting the study samples can reduce the matrix effect. Use the same diluent that was employed for the standard curve.

                                                            Weak or no signal

                                                            Possible cause: too brief incubation period.
                                                            Corresponding solution: incubate the study sample overnight or follow the guidelines provided by the manufacturer.

                                                            Poor reproducibility

                                                            Possible cause: samples and kit controls were at different temperatures.
                                                            Corresponding solution: allow the study samples, kit controls, and sample diluent to come at room temperature. Generally, a larger volume of study samples will require an extended equilibration period. If a water bath is used to achieve equilibrium, ensure it is at room temperature.

                                                            No color development or slow color development

                                                            Possible cause: detection reagent is contaminated, too old, or utilized at the wrong pH.
                                                            Corresponding solution: use freshly prepared detection reagents. Reagents with contaminants, such as peroxidise and sodium azide, can impact the substrate reaction. Hence, avoid reagents that contain these preservatives.

                                                            Low sensitivity

                                                            Possible cause: incorrect plate reader settings
                                                            Corresponding solution: set the plate reader at the right excitation/emission wavelength or absorbance wavelength in fluorescent detection.

                                                            Large coefficient of variation

                                                            Possible cause: cross-well contamination.
                                                            Corresponding solution: ensure that the reagent does not touch the sealer when reusing these plate sealers. Besides, care is necessary when using the same tips for adding reagents.

                                                            High background

                                                            Possible cause: wells are contaminated or insufficiently washed.
                                                            Corresponding solution: increase the total number of washes or the soaking duration between washes. A sealer should also be used to avoid cross-well contamination. Moreover, multi-channel pipettes can help deliver the reagent without touching the plate.

                                                            Positive data seen in negative controls

                                                            Possible cause: use of too much antibody, causing non-specific binding.
                                                            Corresponding solution: always verify the recommended antibody concentration. If necessary, use less antibody.

                                                            Conclusion

                                                            ELISA assays are a robust technique for studying analytes in complex materials. However, ELISA method development requires an in-depth understanding of the target analyte, study matrix, and assay format. NorthEast Biolabs offers reliable ELISA services, specializing in ELISA method development. As industry leaders, we support every aspect of drug discovery and development. NorthEast Biolabs can develop robust ELISA assays and deliver accurate, reliable results in a cost-effective and timely manner.

                                                            Registered And Inspected By Various Regulatory Agencies

                                                            Speak To Our Scientist About Your ELISA Assay Development & Method Development: A Step-by-Step Guide

                                                            SPEAK TO OUR SCIENTISTS

                                                            Similar Learning Center Articles

                                                            • Assay Development: A Comprehensive Guide to Types, Processes, and Applications in Drug Discovery

                                                            • Understanding Cytokines: Their Role in Immunity, Inflammation, and Disease

                                                            • Comprehensive Guide to Flow Cytometry: Principles, Process, and Applications

                                                            • ELISA Assays – Methods, Formats, and Applications

                                                            • Comprehensive Guide to ELISA Assay Validation: Best Practices & Key Insights

                                                            • Introduction to Immunogenicity Assays on Meso Scale Discovery

                                                            • Complete Guide On Anti Drug Antibody (ADA) Assay Development, Immunogenicity Assessment, And FDA Guidance

                                                            • Meso Scale Discovery: ECL Multiplex Assays For Cytokine ELISA, Immunogenicity, & PK

                                                            • Drug Discovery and Development Process

                                                            • The Basics of Bioanalysis: How Do We Develop and Validate Your Bioanalytical Method?

                                                            • Complete Guide On LC-MS: Working, Analysis & Methods

                                                            • Complete Guide To Achieve Reliable Quantitative LC-MS Measurements

                                                            • Introduction to Pharmacokinetics (PK)

                                                            • Complete Guide On IND Enabling GLP Toxicology Studies

                                                            • Importance Of Bioavailability And Bioequivalence In Drug Development

                                                            • Good Laboratory Practices for Bioanalytical Laboratories

                                                            Relevant Regulatory References

                                                            • Immunogenicity Testing Of Therapeutic Protein Products – Guidance For Industry (2019)

                                                            • Immunogenicity Assays – Design and Validation of Immunoassays to Detect Anti-Drug Antibodies

                                                            • Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies

                                                            • Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points

                                                            • Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products

                                                            • Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA

                                                            • An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen

                                                            view more

                                                            Explore our Expertise

                                                            • Mass Spectrometry (LC-MS)

                                                            • Meso Scale Discovery Assay

                                                            • ELISA Assay

                                                            • Flow Cytometry

                                                            • qPCR Analysis, ddPCR Assay

                                                            • Western Blot, In Cell Western

                                                            Contact A Scientist With Your Bioanalytical Study Details

                                                            We Will Respond Within 1 Business Day

                                                            Expertise

                                                            Expertise

                                                            • Mass Spectrometry (LC-MS)
                                                            • Meso Scale Discovery Assay
                                                            • ELISA Assay
                                                            • Flow Cytometry
                                                            • qPCR Analysis, ddPCR Assay
                                                            • Western Blot, In Cell Western

                                                            Services

                                                            Services

                                                            • Pharmacokinetics (PK) Study
                                                            • ADA Assay, Neutralizing Antibody Assay
                                                            • Multiplex Cytokine Assay
                                                            • Biomarker Assay
                                                            • Cell-Based Assay
                                                            • Bioanalytical Assay Validation

                                                            Solutions

                                                            Solutions

                                                            • Clinical CRO
                                                            • GLP Laboratory
                                                            • Preclinical CRO
                                                            • Method Development, Validation, And Transfer
                                                            • Analytical Testing

                                                            About Us

                                                            About Us

                                                            • Overview
                                                            • Leadership
                                                            • Facility and Equipment
                                                            • Quality and Compliance
                                                            • Therapeutic Areas
                                                            • Why Us?
                                                            • Values
                                                            • Process
                                                            • Partners
                                                            • Careers

                                                            Resources

                                                            Resources

                                                            • Learning Center
                                                            • Blog
                                                            • Case Study
                                                            • Video Brochures
                                                            • News and Events
                                                            • Testimonials
                                                            • Contact Us
                                                            NorthEast BioLab Logo Agile Bioanalytical Services CRO
                                                            sales@nebiolab.comFollow Up On Email
                                                            (203) 361 3780Follow Up On Phone

                                                            35 Worth Ave, Hamden, CT 06518

                                                            • Good Laboratory Practice for Nonclinical Laboratory Studies | NorthEast BioLab
                                                            • Food and Drug Administration (FDA | NorthEast BioLab
                                                            • clia
                                                            • United States Drug Enforcement Administration | NorthEast BioLab
                                                            • Department of Consumer Protection | NorthEast BioLab
                                                            • Privacy Policy
                                                            • Terms of Use
                                                            • Sitemap
                                                            All rights reserved.